BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 12709926)

  • 21. Contribution of multiple thrombophilic and transient risk factors in the development of cerebral venous thrombosis.
    Libourel EJ; ten Kate MK; Brouwer JL; Veeger NJ; van der Meer J
    Thromb Res; 2007; 121(3):301-7. PubMed ID: 17543373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Who should be tested for thrombophilia?
    Simioni P
    Curr Opin Hematol; 2006 Sep; 13(5):337-43. PubMed ID: 16888438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Venous and arterial thrombosis during oral contraceptive use: risks and risk factors.
    Tanis BC; Rosendaal FR
    Semin Vasc Med; 2003 Feb; 3(1):69-84. PubMed ID: 15199494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of family history in identifying women with thrombophilia and higher risk of venous thromboembolism during oral contraception.
    Cosmi B; Legnani C; Bernardi F; Coccheri S; Palareti G
    Arch Intern Med; 2003 May; 163(9):1105-9. PubMed ID: 12742811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Venous thromboembolism in young female while on oral contraceptives: high frequency of inherited thrombophilia and analysis of thrombotic events in 400 czech women.
    Dulícek P; Malý J; Pecka M; Beránek M; Cermáková E; Malý R
    Clin Appl Thromb Hemost; 2009 Oct; 15(5):567-73. PubMed ID: 19117968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The essential role of genetic counseling in inherited thrombophilia.
    Lochhead P; Miedzybrodzka Z
    Semin Hematol; 2007 Apr; 44(2):126-9. PubMed ID: 17433905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recommendations for screening for thrombophilic tendencies in teenage females prior to contraceptive initiation.
    Savelli SL; Kerlin BA; Springer MA; Monda KL; Thornton JD; Blanchong CA
    J Pediatr Adolesc Gynecol; 2006 Aug; 19(4):313-6. PubMed ID: 16873040
    [No Abstract]   [Full Text] [Related]  

  • 28. Thromboembolism in women.
    Martinelli I
    Semin Thromb Hemost; 2006 Oct; 32(7):709-15. PubMed ID: 17024598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of thrombophilic gene mutations among patients experiencing recurrent miscarriage and deep vein thrombosis.
    Coulam CB; Wallis D; Weinstein J; DasGupta DS; Jeyendran RS
    Am J Reprod Immunol; 2008 Nov; 60(5):426-31. PubMed ID: 18803625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic susceptibility to venous thrombosis.
    Seligsohn U; Lubetsky A
    N Engl J Med; 2001 Apr; 344(16):1222-31. PubMed ID: 11309638
    [No Abstract]   [Full Text] [Related]  

  • 31. Thrombophilias in adolescents: the past, present and future.
    Dietrich JE; Hertweck SP
    Curr Opin Obstet Gynecol; 2008 Oct; 20(5):470-4. PubMed ID: 18797270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral contraception and thrombophilia.
    Blickstein D; Blickstein I
    Curr Opin Obstet Gynecol; 2007 Aug; 19(4):370-6. PubMed ID: 17625421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening for thrombophilia in high-risk situations: a meta-analysis and cost-effectiveness analysis.
    Wu O; Robertson L; Twaddle S; Lowe G; Clark P; Walker I; Brenkel I; Greaves M; Langhorne P; Regan L; Greer I;
    Br J Haematol; 2005 Oct; 131(1):80-90. PubMed ID: 16173967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A negative personal and family history for venous thrombotic events is not sufficient to exclude thrombophilia in patients with cerebral venous thrombosis.
    Amberger N; Masuhr F; Valdueza JM; Vetter B; Weih M
    Eur J Neurol; 2004 Aug; 11(8):555-8. PubMed ID: 15272901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study.
    Wu O; Robertson L; Langhorne P; Twaddle S; Lowe GD; Clark P; Greaves M; Walker ID; Brenkel I; Regan L; Greer IA
    Thromb Haemost; 2005 Jul; 94(1):17-25. PubMed ID: 16113779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between sex hormone-binding globulin levels and activated protein C resistance in explaining the risk of thrombosis in users of oral contraceptives containing different progestogens.
    van Vliet HA; Frolich M; Christella M; Thomassen LG; Doggen CJ; Rosendaal FR; Rosing J; Helmerhorst FM
    Hum Reprod; 2005 Feb; 20(2):563-8. PubMed ID: 15539435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral contraceptives and the risk of venous thrombosis.
    Vandenbroucke JP; Rosing J; Bloemenkamp KW; Middeldorp S; Helmerhorst FM; Bouma BN; Rosendaal FR
    N Engl J Med; 2001 May; 344(20):1527-35. PubMed ID: 11357157
    [No Abstract]   [Full Text] [Related]  

  • 38. Thrombophilia screening in asymptomatic children.
    Thornburg CD; Dixon N; Paulyson-Nuñez K; Ortel T
    Thromb Res; 2008; 121(5):597-604. PubMed ID: 17631949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiology and risk factors of venous thromboembolism.
    Ageno W; Squizzato A; Garcia D; Imberti D
    Semin Thromb Hemost; 2006 Oct; 32(7):651-8. PubMed ID: 17024592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Inherited thrombophilia].
    De Stefano V
    G Ital Nefrol; 2009; 26 Suppl 46():14-9. PubMed ID: 19644814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.